HPM Partners »

Halozyme Therapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 296k 40.68
2023-12-31 $10M 270k 36.96
2023-09-30 $9.7M 253k 38.20
2023-06-30 $9.3M 258k 36.07
2023-03-31 $9.8M 256k 38.19
2022-12-31 $15M 259k 56.90
2022-09-30 $265k 6.7k 39.55
2022-06-30 $262k 6.0k 44.01